In the BioHarmony Drug Report Database

"Preview" Icon

Insulin aspart

Fiasp, Novolog, NovoMix, NovoRapid (insulin aspart) is a protein pharmaceutical. Insulin aspart was first approved as Fiasp on 1999-09-07. It has been approved in Europe to treat diabetes mellitus.

 

Trade Name

 

Fiasp, NovoMix, NovoRapid
 

Common Name

 

insulin aspart
 

ChEMBL ID

 

CHEMBL1201496
 

Indication

 

diabetes mellitus
 

Drug Class

 

Image (chem structure or protein)

Insulin aspart structure rendering